Stay updated on MiST: Multi-drug Phase II Clinical Trial
Sign up to get notified when there's something new on the MiST: Multi-drug Phase II Clinical Trial page.

Latest updates to the MiST: Multi-drug Phase II Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe changes are limited to system revision notices and a footer link modification, with no impact on the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedThe additions explain that PubMed publications are auto-filled and add a revision tag (v3.3.2); the deletions describe the PubMed source and include an older revision tag (v3.2.0).SummaryDifference0.1%

- Check48 days agoChange DetectedThe government funding lapse notice banner was removed from the page. It previously warned that information might not be up to date and directed users to cc.nih.gov and opm.gov for operating status.SummaryDifference0.4%

- Check62 days agoChange DetectedNo additions or deletions were detected on the study record page. The content remains focused on the MiST trial’s design, eligibility criteria, outcomes, and collaborators.SummaryDifference0.4%

- Check91 days agoChange DetectedAdded a government funding lapse notice and a version upgrade to v3.2.0; removed the previous v3.1.0 tag. This introduces critical information about availability and processing, while updating the platform version.SummaryDifference3%

- Check98 days agoChange DetectedCore content updated with a terminology rearrangement from 'Malignant mesothelioma' to 'Mesothelioma, malignant' and a version bump to v3.1.0, indicating an overall refresh rather than changes to pricing or availability.SummaryDifference0.2%

Stay in the know with updates to MiST: Multi-drug Phase II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MiST: Multi-drug Phase II Clinical Trial page.